DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Graft-versus-host disease	R-HSA-1643685	map05332	xylazine	5707	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	xylazine	5707	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	xylazine	5707	drug-path
Wnt signaling pathway	R-HSA-195721	map04310	xylazine	5707	drug-path
Olfactory transduction	R-HSA-9751605	map04740	xylazine	5707	drug-path
Tight junction	R-HSA-2134514	map04530	xylazine	5707	drug-path
Asthma	R-HSA-444620	map05310	xylazine	5707	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	xylazine	5707	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	xylazine	5707	drug-path
Huntington's disease	R-HSA-1643685	0	xylazine	5707	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	xylazine	5707	drug-path
Parkinson's disease	R-HSA-1643685	0	xylazine	5707	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	xylazine	5707	drug-path
Colorectal cancer	R-HSA-4791275	map05210	xylazine	5707	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	cinchonine	1645	drug-path
Olfactory transduction	R-HSA-9751605	map04740	cinchonine	1645	drug-path
Non-small cell lung cancer	R-HSA-5619066	map05223	cinchonine	1645	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	cinchonine	1645	drug-path
RNA polymerase	R-HSA-73864	map03020	cinchonine	1645	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	sparteine	644020	drug-path